Richard P M Houben

Title: Innovations in Blood Glucose Monitoring by Richard P M Houben

Introduction

Richard P M Houben is an accomplished inventor based in Berg & Terblijt, Netherlands. He has made significant contributions to the field of medical technology, particularly in the area of blood glucose monitoring. His innovative approach aims to enhance the management of diabetes through advanced monitoring systems.

Latest Patents

Richard P M Houben holds a patent for a method of obtaining a measure of blood glucose. This patent describes an implantable system and method for monitoring pancreatic beta cell electrical activity in a patient. The system is designed to provide a measure of a patient's insulin demand and blood glucose level. A stimulus generator is controlled to deliver stimulus pulses that synchronize pancreatic beta cell depolarization, producing an enhanced electrical signal that is sensed and processed. The processing of this signal allows for the determination of the start and end of beta cell depolarization, which is crucial for understanding insulin demand. To minimize cardiac interference, each stimulus pulse is timed to be offset from the QRS signal, which can disrupt pancreas sensing. Additionally, the signals are processed by a correction circuit to remove artifacts from various sources, ensuring accurate readings.

Career Highlights

Richard P M Houben is currently associated with Medtronic, Inc., a leading company in medical technology. His work focuses on developing innovative solutions for diabetes management, leveraging his expertise in electrical activity monitoring. His contributions have the potential to significantly improve patient outcomes in diabetes care.

Collaborations

Richard collaborates with notable colleagues, including Alexis C M Renirie and Koen J Weijand. Their combined expertise fosters a collaborative environment that drives innovation in medical technology.

Conclusion

Richard P M Houben's work in blood glucose monitoring exemplifies the intersection of technology and healthcare. His innovative patent and contributions to Medtronic, Inc. highlight the importance of advancements in diabetes management. Through his efforts, he is paving the way for improved patient care and outcomes in the field of endocrinology.